Healthcare provider profile · identity verified

Timothy Helder, MD

Internal Medicine · GREENVILLE, MI · NPI 1306888367

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	348	103
Levothyroxine Sodium	Levothyroxine Sodium	292	77
Omeprazole	Omeprazole	253	79
Amlodipine Besylate	Amlodipine Besylate	248	70
Lisinopril	Lisinopril	182	50
Gabapentin	Gabapentin	171	41
Metoprolol Succinate	Metoprolol Succinate	156	43
Furosemide	Furosemide	134	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	129	27
Duloxetine Hcl	Duloxetine Hcl	118	25
Metformin Hcl	Metformin Hcl	116	34
Pravastatin Sodium	Pravastatin Sodium	116	33
Losartan Potassium	Losartan Potassium	113	32
Simvastatin	Simvastatin	109	30
Tamsulosin Hcl	Tamsulosin Hcl	101	29
Albuterol Sulfate Hfa	Albuterol Sulfate	98	43
Escitalopram Oxalate	Escitalopram Oxalate	96	28
Alprazolam	Alprazolam	92	26
Pioglitazone Hcl	Pioglitazone Hcl	88	28
Pantoprazole Sodium	Pantoprazole Sodium	85	22
Hydrochlorothiazide	Hydrochlorothiazide	84	25
Rosuvastatin Calcium	Rosuvastatin Calcium	82	24
Eliquis	Apixaban	78	22
Meloxicam	Meloxicam	70	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	21
Trazodone Hcl	Trazodone Hcl	67	18
Zolpidem Tartrate	Zolpidem Tartrate	64	12
Lovastatin	Lovastatin	62	17
Potassium Chloride	Potassium Chloride	58	20
Glimepiride	Glimepiride	55	14
Sertraline Hcl	Sertraline Hcl	54	16
Metoprolol Tartrate	Metoprolol Tartrate	53	16
Benazepril Hcl	Benazepril Hcl	52	13
Metformin Hcl Er	Metformin Hcl	51	16
Montelukast Sodium	Montelukast Sodium	50	13
Prednisone	Prednisone	45	40
Carvedilol	Carvedilol	44	12
Clonazepam	Clonazepam	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	19
Methocarbamol	Methocarbamol	42	suppressed
Diazepam	Diazepam	41	11
Naproxen	Naproxen	40	23
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Xarelto	Rivaroxaban	40	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	39	suppressed
Celecoxib	Celecoxib	39	14
Tramadol Hcl	Tramadol Hcl	39	13
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Januvia	Sitagliptin Phosphate	38	12
Atenolol	Atenolol	37	11
Pregabalin	Pregabalin	37	suppressed
Ezetimibe	Ezetimibe	36	12
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Baclofen	Baclofen	34	suppressed
Cephalexin	Cephalexin	34	25
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Estradiol	Estradiol	31	suppressed
Valsartan	Valsartan	30	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Nystatin	Nystatin	21	suppressed
Dutasteride	Dutasteride	20	suppressed
Ozempic	Semaglutide	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Famotidine	Famotidine	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Irbesartan	Irbesartan	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Glipizide	Glipizide	12	suppressed
Testosterone	Testosterone	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Azithromycin	Azithromycin	11	11
Ibuprofen	Ibuprofen	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error